我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

内皮素-1对大鼠骨髓内皮前体细胞增殖、细胞周期及NO分泌功能的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2008年第4期
页码:
376-380
栏目:
基础研究
出版日期:
2008-08-20

文章信息/Info

Title:
Effect of endothelin-1 on proliferation, cell cycle and NO secreting function of endothelial progenitor cells from rat bone marrow
作者:
韩凯; 许旭东; 马彦卓; 曹艳杰; 王海昌
第四军医大学西京医院心脏内科，陕西 西安 710033
Author(s):
HAN Kai;  XU XuDong;  MA YanZhuo;  CAO YanJie;  WANG HaiChang
Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710033, Shaanxi, China
关键词:
内皮祖细胞; 内皮素; 大鼠
Keywords:
endothelial progenitor cell;  endothelin-1;  rat
分类号:
R541. 4
DOI:
-
文献标识码:
A
摘要:
目的 探讨内皮素-1(ET-1)对大鼠骨髓内皮前体细胞(EPC)增殖、细胞周期及一氧化氮(NO)分泌功能的影响。方法 采用密度梯度离心法获取大鼠骨髓单核细胞，在M199培养液中培养扩增EPC并进行鉴定。不同浓度ET-1(A组：0 mol /L、B组：10-9 mol /L、C组：10-8 mol/L、D组：10-7 mol /L、E组：10-6 mol /L)作用于EPC，MTT法检测ET1对EPC增殖能力的影响，流式细胞仪检测ET1对EPC细胞周期的影响，硝酸还原酶法检测细胞培养液中NO含量的变化，观察ET-1对EPC的NO分泌功能的影响。结果 与对照组(A组，0405±0017)相比，ET-1浓度C组（0434±0 016）、D组（0463±0016）、E组（0473±0015）EPC增殖能力显著增高 (n=8，P<001)。EPC的G0/G1期细胞百分数C组（5728±365）%、D组（4499±319）%、E组（4029±374）%较对照组（7055±137）%明显降低(n=5，P<001)，EPC的S期细胞百分数C组（2675±287）%、D组（3279±241）%、E组（3574±294）%较对照组（2004±164）%明显升高(n=5，P<001)，EPC的G2/M期细胞百分数C组（1596±171）%、D组（2222±222）%、E组（2364±286）%较对照组（941±081）%明显升高(n=5，P<001)。EPC培养液中NO含量(μmol/L) ET-1浓度C组（1170±180）、D组（1569±186）、E组（1689±155）较对照组（745±241）明显增加(n=8，P<001)。B组检测结果与对照组相比，各项指标均无统计学差异。结论 ET-1能够促进EPC的增殖，促进细胞向S期和G2期的转化，并提高细胞NO分泌功能，可能参与缺血性疾病的血管再生过程。
Abstract:
AIM To study the effects of endothelin-1 on proliferation, cell cycle and NO secreting function of endothelial progenitor cells from rat bone marrow. METHODS Mononuclear cells were collected from rat bone marrow by density gradient centrifugation, cultured with medium 199 and were identified to be EPC on day 6 by DiⅠ-ac-LDL and FITC-UEA-Ⅰ double staining. Different concentrations of ET1 (group A, 0 mol /L; group B, 10-9 mol /L; group C, 10-8 mol/L; group D, 10-7 mol /L; group E, 10-6 mol /L) were added into culture medium to detect the effect on EPC. MTT assay was performed to detect the effect of ET-1 on the multiplication ability of EPC and Flow cytometry was employed to detect the cell cycle. NO content was measured in the cell culture medium by nitrate reductase method to find the promotion of ET-1 on cell functions. RESULTS Compared with that in the control group (group A, 0405±0017), the proliferation of EPC greatly enhanced in ET-1 group (group C, 0434±0016; group D, 0463±0015; group E, 0473±0015)(n=8, P<001). The amount of EPC in ET-1 group in G0/G1 phase (group C, 5728%±365%; group D, 4499%±319%; group E, 4029%±374%) was significantly lower than those in control group (group A, 7055%±137%)(n=5, P<001). Compare with that in the control group (2004%±164%)(941%±081%), the amount of EPC in ET1 group in S phase (group C, 2675%±287%; group D, 3279%±241%; group E, 3574%±294%) and in G2/M phase (group C, 1596%±171%; group D, 2222%±222%; group E, 2364%±286%) increased (n=5, P<001). Compare with that in the control group(group A, 745±241), NO secreting function of EPC increased in ET-1 group (group C, 1170±180; group D, 1569±186; group E, 1689±155)(n=8, P<001). Group B showed no or only minor difference as compared with control group. CONCLUSION ET-1 stimulates EPC proliferation, promotes the division and multiplication of EPC and enhances the NO secretion capacity.

参考文献/References

［1］ Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis［J］. Science, 1997, 275(5302):964-967.

［2］ Takahashi T, Kalka C, Masuda H, et al. Ischemia and cytokineinduced mobilization of bone marrowderived endothelial progenitor cells for neovascularization［J］. Nat Med, 1999, 5(4):434-438.

［3］ 王学忠，洪小苏. 内皮素1与血管生成的研究［J］. 医学综述， 2004, 10(7):398-400.

［4］ 郑奇军，刘维永. 内皮前体细胞与血管新生［J］. 心脏杂志， 2004, 16(5):472-473.

［5］ Boyer M, Townsend LE, Vogel LM, et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood［J］. J Vasc Surg, 2000, 31 (l Pt 1):181-189.

［6］ Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization［J］. Trends Cardiovasc Med, 2003, 13(5):201-206.

［7］ Hristov M, Erl W, Weber PC. Endothelial progenitor cells: mobilization, differentiation, and homing［J］. Arterioscler Thromb Vasc Biol, 2003, 23(7):1185-1189.

［8］ Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization［J］. Proc Natl Acad Sci U S A, 2000, 97(7):3422-3427.

［9］ Murayama T, Losordo D, Isner J, et al. Determination of bone marrowderived endothelial progenitor cell significance in angiogenic growth factorinduced neovascularization in vivo［J］. Exp Hematol, 2002, 30(8):967-972.

［10］Noiri E, Hu Y, Bahou WF, et al. Permissive role of nitric oxide in endothelininuced migration of endothelial cells［J］. J Biol Chem, 1997, 272(3):1747-1752.

［11］Noiri E, Lee E, Testa J, et al. Podokinesis in endothelial cell migration: role of nitric oxide［J］. Am J Physiol, 1998, 274(1Pt 1):C236-C244.

［12］Salani D, Taraboletti G, Rosano L, et al. Endotheline1 induces an angiogensic pheenotype in cultured endothelial cells and stimulates neovascularization in vivo［J］. Am J Pathol, 2000, 157(5):1703-1711.

［13］Bagnato A, Spinella F. Emerging role of endothelin1 in tumor angiogensis［J］. Treads Endocrinol Metab, 2003, 14(1):44-50.

［14］Giaid A, Saleh D, Yanagisawa M, et al. Endothelin1 immuoreactivity and RNA in the transplanted human heart［J］. Transplantation, 1995, 59(9):1308-1313.

［15］Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrowderived endothelial progenitor cells［J］. EMBO J, 1999, 18(14):3964-3972.

备注/Memo

备注/Memo:
收稿日期：2007-10-15.基金项目：国家自然科学基金项目资助（30600580） 通讯作者：王海昌，教授，主任医师，主要从事冠心病的基础与临床研究Email:wanghc@fmmu.edu.cn 作者简介：韩凯，硕士生Email:kaikblue@sina.com.cn 作者简介：何燕萍，主治医师，博士生Email：hyping@fmmu.edu.cn
更新日期/Last Update: